Venkat Jasti, chairman and chief executive officer, Suven Lifesciences says FY17 looks to be a more promising year and he hopes to log a revenue growth of 20 percent in the same year.
first published: Nov 26, 2015 02:54 pm
A collection of the most-viewed Moneycontrol videos.

Live: Can Nifty reach its all-time high levels this week? | Opening Bell

This Tenant says Andheri West is better than SOBO | The tenant

Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live
You are already a Moneycontrol Pro user.

